首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1637687

2031 年亞太地區放射腫瘤學市場預測 - 區域分析 - 按類型和應用

Asia Pacific Radiation Oncology Market Forecast to 2031 - Regional Analysis - by Types and Application

出版日期: 2024年11月22日 | 出版商:

The Insight Partners | 英文 89 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

2023年亞太地區放射腫瘤市值為11.0574億美元，預計2031年將達到34.1789億美元；預計2023年至2031年複合年成長率為15.1%。

放射腫瘤學策略措施推動亞太放射腫瘤學市場

放射腫瘤學在癌症治療方面具有巨大的潛力。此外，市場參與者在產品開發、創新、產品發布、產品批准、合併、收購和合作夥伴關係等方面不斷發展放射治療預計將有助於市場成長。市場上最近採取的一些策略性舉措是

2024 年 5 月，Elekta 推出了最新的直線加速器 (linac) Evo，這是一款具有新型高清 AI 增強成像的 CT-Linac，能夠提供離線和線上自適應放射治療以及改進的標準影像引導放射治療。
2024 年 5 月，The Icon Group 與 Cyberknife Australia Pty Ltd 合作建立多達 6 家新的放射腫瘤診所（擬成立合資企業），將使用「Cyberknife」系統提供放射腫瘤治療。
2024 年5 月，GE HealthCare 推出了Revolution RT，這是一種新型放射治療電腦斷層掃描(CT) 解決方案，具有創新的硬體和軟體解決方案，有助於提高成像準確性，同時簡化模擬工作流程，為臨床醫生和患者提供更個人化和無縫的腫瘤護理路徑體驗。
2024 年4 月，Accuray Incorporated 在ESTRO 2024 上展示了旨在改善癌症治療體驗的硬體和軟體的進步。所需的技術。
2023 年 9 月，MVision AI 推出了第一個全面的基於指南的分割 (GBS) 解決方案，用於有效的放射治療輪廓繪製。 Guide 有助於臨床團隊準確評估人工智慧生成的結構，從而使他們能夠提高輪廓繪製技能。驗證可以對輪廓進行視覺和體積比較，方便診所觀察相似點和差異。 Guide verify 和 Contour+ 的組合實施涵蓋了放射治療輪廓的所有臨床需求。

因此，放射腫瘤學市場的市場參與者紛紛採取策略性舉措，預計將擴大市場成長並為放射腫瘤學市場創造充足的機會。

亞太地區放射腫瘤學市場概況

由於技術的重大進步，放射腫瘤學領域在中國發展迅速。合資企業在提高放射腫瘤系統的可及性方面發揮了至關重要的作用。透過這些舉措，公司也專注於開發高科技治療產品。中國同輻射公司（CIRC）與美國放射治療系統開發商Accuray於2019年1月成立了合資公司。這些措施顯示了中國致力於發展國內放射腫瘤學技術，這將為未來幾年的放射腫瘤學市場帶來值得關注的前景。

亞太地區放射腫瘤學市場收入及 2031 年預測（百萬美元）

亞太地區放射腫瘤學市場細分

亞太地區放射腫瘤學市場按類型、應用和國家分類。

根據類型，亞太地區放射腫瘤學市場分為外照射放射治療和內照射放射治療。 2023 年，體外放射治療領域將佔據更大的市場佔有率。

從應用來看，亞太地區放射腫瘤市場分為乳癌、攝護腺癌、肺癌、頭頸癌、子宮頸癌等。 2023 年，乳癌細分市場佔據最大的市場佔有率。

依國家/地區分類，亞太地區放射腫瘤學市場分為中國、日本、印度、澳洲、韓國和亞太地區其他地區。 2023年，中國在亞太地區放射腫瘤市場佔有率中佔據主導地位。

Varian Medical Systems Inc、Elekta AB、Accuray Incorporated、IBA Worldwide (Ion Beam Applications SA)、Becton Dickinson and Co、Mevion Medical Systems、NTP RADIOISOTOPES、Mallinckrodt Plc、Panacea Medical Technologies Pvt. Ltd、和 Curium 是亞太地區放射腫瘤學市場上的一些領先公司。

Radiation Oncology holds tremendous potential in cancer treatment. Additionally, constant evolution in radiotherapy by the market players in terms of product development, innovation, product launch, product approval, merger, acquisition and partnerships, and others is expected to contribute the market growth. Some of the recent strategic initiatives taken place in the market are

In May 2024, Elekta launched its latest linear accelerator (linac), Evo, a CT-Linac with new high-definition AI enhanced imaging, capable of delivering offline and online adaptive radiation therapy as well as improved standard image-guided radiation therapy treatments.
In May 2024, The Icon Group collaborated with Cyberknife Australia Pty Ltd to establish up to 6 new radiation oncology clinics (proposed joint venture), which will provide radiation oncology treatments using the 'Cyberknife' system.
In May 2024, GE HealthCare launched Revolution RT, a new radiation therapy computed tomography (CT) solution with innovative hardware and software solutions to help increase imaging accuracy, while simplifying simulation workflow for a more personalized and seamless oncology care pathway experience for clinicians and patients.
In April 2024, Accuray Incorporated showcased advancement in hardware and software designed to improve the cancer treatment experience, at ESTRO 2024. The latest generation CyberKnife and Radixact platforms provide medical care teams with the technology necessary for expanding the curative power of radiation therapy and delivering on the focus of this year's congress, bridging the care gap.
In September 2023, MVision AI launched the first comprehensive Guideline-Based Segmentation (GBS) solution for effective radiation therapy contouring. Guide facilitates clinical teams to accurately evaluate AI-generated structures, thus enabling them to refine their contouring skills. Verify allows visual and volumetric comparison of contours, facilitating clinics to observe similarities and differences. The combined implementation of Guide Verify and Contour+ encompasses all clinical needs in radiotherapy contouring.

Therefore, surging strategic initiatives among market players operating in radiation oncology market which are expected to amplify the market growth and create ample opportunities for the radiation oncology market.

Asia Pacific Radiation Oncology Market Overview

The field of radiation oncology has been developing quickly in China due to significant technological advancements. Joint ventures have played a crucial role in increasing the accessibility of radiation oncology systems. With these initiatives, companies also focus on developing high-tech therapy products. China Isotope and Radiation Corporation (CIRC) and Accuray, a US-based developer of radiotherapy systems, established a joint venture in January 2019. This project uses Accuray's cutting-edge treatment solutions and local manufacturing capabilities to address the unmet needs in the Chinese market. Such initiatives demonstrate China's dedication to developing radiation oncology skills within the country, which would generate noteworthy prospects for the radiation oncology market in the coming years.

Asia Pacific Radiation Oncology Market Revenue and Forecast to 2031 (US$ Million)

Asia Pacific Radiation Oncology Market Segmentation

The Asia Pacific radiation oncology market is categorized into types, application, and country.

Based on types, the Asia Pacific radiation oncology market is bifurcated into external beam radiation therapy and internal beam radiation therapy. The external beam radiation therapy segment held a larger market share in 2023.

In terms of application, the Asia Pacific radiation oncology market is categorized into breast cancer, prostate cancer, lung cancer, head and neck cancer, cervical cancer, and others. The breast cancer segment held the largest market share in 2023.

By country, the Asia Pacific radiation oncology market is segmented into the China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific radiation oncology market share in 2023.

Varian Medical Systems Inc, Elekta AB, Accuray Incorporated, IBA Worldwide (Ion Beam Applications SA), Becton Dickinson and Co, Mevion Medical Systems, NTP RADIOISOTOPES, Mallinckrodt Plc, Panacea Medical Technologies Pvt. Ltd,, and Curium are some of the leading companies operating in the Asia Pacific radiation oncology market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. Asia Pacific Radiation Oncology Market - Key Market Dynamics

4.1 Market Drivers:
- 4.1.1 Increasing Prevalence of Cancer
- 4.1.2 Initiatives to Support Developments in Radiation Oncology
4.2 Market Restraints
- 4.2.1 High Cost of Radiotherapy Equipment
4.3 Market Opportunities
- 4.3.1 Strategic Initiatives in Radiation Oncology
4.4 Future Trends
- 4.4.1 Technological Advancement in Radiation Oncology
4.5 Impact of Drivers and Restraints:

5. Radiation Oncology Market - Asia Pacific Market Analysis

5.1 Radiation Oncology Market Revenue (US$ Million), 2021-2031

6. Asia Pacific Radiation Oncology Market Analysis - by Types

6.1 External Beam Radiation Therapy
- 6.1.1 Overview
- 6.1.2 External Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
6.2 Internal Beam Radiation Therapy
- 6.2.1 Overview
- 6.2.2 Internal Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)

7. Asia Pacific Radiation Oncology Market Analysis - by Application

7.1 Breast Cancer
- 7.1.1 Overview
- 7.1.2 Breast Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Prostate Cancer
- 7.2.1 Overview
- 7.2.2 Prostate Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Lung Cancer
- 7.3.1 Overview
- 7.3.2 Lung Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Head and Neck Cancer
- 7.4.1 Overview
- 7.4.2 Head and Neck Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7.5 Cervical Cancer
- 7.5.1 Overview
- 7.5.2 Cervical Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)

8. Asia Pacific Radiation Oncology Market - Country Analysis

8.1 Asia Pacific
- 8.1.1 Asia Pacific: Radiation Oncology Market - Revenue and Forecast Analysis - by Country
  - 8.1.1.1 China: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
    - 8.1.1.1.1 China: Radiation Oncology Market Breakdown, by Types
    - 8.1.1.1.2 China: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
    - 8.1.1.1.3 China: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
    - 8.1.1.1.4 China: Radiation Oncology Market Breakdown, by Application
  - 8.1.1.2 Japan: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
    - 8.1.1.2.1 Japan: Radiation Oncology Market Breakdown, by Types
    - 8.1.1.2.2 Japan: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
    - 8.1.1.2.3 Japan: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
    - 8.1.1.2.4 Japan: Radiation Oncology Market Breakdown, by Application
  - 8.1.1.3 India: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
    - 8.1.1.3.1 India: Radiation Oncology Market Breakdown, by Types
    - 8.1.1.3.2 India: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
    - 8.1.1.3.3 India: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
    - 8.1.1.3.4 India: Radiation Oncology Market Breakdown, by Application
  - 8.1.1.4 Australia: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
    - 8.1.1.4.1 Australia: Radiation Oncology Market Breakdown, by Types
    - 8.1.1.4.2 Australia: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
    - 8.1.1.4.3 Australia: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
    - 8.1.1.4.4 Australia: Radiation Oncology Market Breakdown, by Application
  - 8.1.1.5 South Korea: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
    - 8.1.1.5.1 South Korea: Radiation Oncology Market Breakdown, by Types
    - 8.1.1.5.2 South Korea: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
    - 8.1.1.5.3 South Korea: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
    - 8.1.1.5.4 South Korea: Radiation Oncology Market Breakdown, by Application
  - 8.1.1.6 Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
    - 8.1.1.6.1 Rest of APAC: Radiation Oncology Market Breakdown, by Types
    - 8.1.1.6.2 Rest of APAC: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
    - 8.1.1.6.3 Rest of APAC: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
    - 8.1.1.6.4 Rest of APAC: Radiation Oncology Market Breakdown, by Application

9. Radiation Oncology Market - Industry Landscape

9.1 Overview
9.2 Growth Strategies in Radiation Oncology Market
9.3 Organic Growth Strategies
- 9.3.1 Overview
9.4 Inorganic Growth Strategies
- 9.4.1 Overview

10. Company Profiles

10.1 Varian Medical Systems Inc
- 10.1.1 Key Facts
- 10.1.2 Business Description
- 10.1.3 Products and Services
- 10.1.4 Financial Overview (Siemens Healthineers AG)
- 10.1.5 SWOT Analysis
- 10.1.6 Key Developments
10.2 Elekta AB
- 10.2.1 Key Facts
- 10.2.2 Business Description
- 10.2.3 Products and Services
- 10.2.4 Financial Overview
- 10.2.5 SWOT Analysis
- 10.2.6 Key Developments
10.3 Accuray Incorporated
- 10.3.1 Key Facts
- 10.3.2 Business Description
- 10.3.3 Products and Services
- 10.3.4 Financial Overview
- 10.3.5 SWOT Analysis
- 10.3.6 Key Developments
10.4 IBA Worldwide (Ion Beam Applications SA)
- 10.4.1 Key Facts
- 10.4.2 Business Description
- 10.4.3 Products and Services
- 10.4.4 Financial Overview
- 10.4.5 SWOT Analysis
- 10.4.6 Key Developments
10.5 Becton Dickinson and Co
- 10.5.1 Key Facts
- 10.5.2 Business Description
- 10.5.3 Products and Services
- 10.5.4 Financial Overview
- 10.5.5 SWOT Analysis
- 10.5.6 Key Developments
10.6 Mevion Medical Systems
- 10.6.1 Key Facts
- 10.6.2 Business Description
- 10.6.3 Products and Services
- 10.6.4 Financial Overview
- 10.6.5 SWOT Analysis
- 10.6.6 Key Developments
10.7 NTP RADIOISOTOPES
- 10.7.1 Key Facts
- 10.7.2 Business Description
- 10.7.3 Products and Services
- 10.7.4 Financial Overview
- 10.7.5 SWOT Analysis
- 10.7.6 Key Developments
10.8 Mallinckrodt Plc
- 10.8.1 Key Facts
- 10.8.2 Business Description
- 10.8.3 Products and Services
- 10.8.4 Financial Overview
- 10.8.5 SWOT Analysis
- 10.8.6 Key Developments
10.9 Panacea Medical Technologies Pvt. Ltd
- 10.9.1 Key Facts
- 10.9.2 Business Description
- 10.9.3 Products and Services
- 10.9.4 Financial Overview
- 10.9.5 SWOT Analysis
- 10.9.6 Key Developments
10.10 Curium
- 10.10.1 Key Facts
- 10.10.2 Business Description
- 10.10.3 Products and Services
- 10.10.4 Financial Overview
- 10.10.5 SWOT Analysis
- 10.10.6 Key Developments

11. Appendix

11.1 About The Insight Partners
11.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. Asia Pacific Radiation Oncology Market Segmentation
Table 2. China: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 3. China: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 4. China: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 5. China: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 6. Japan: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 7. Japan: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 8. Japan: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 9. Japan: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 10. India: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 11. India: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 12. India: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 13. India: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 14. Australia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 15. Australia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 16. Australia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 17. Australia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 18. South Korea: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 19. South Korea: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 20. South Korea: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 21. South Korea: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 22. Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 23. Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 24. Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 25. Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 26. Recent Organic Growth Strategies in Radiation Oncology Market
Table 27. Recent Inorganic Growth Strategies in the Radiation Oncology Market
Table 28. Glossary of Terms, Radiation Oncology Market

List Of Figures

Figure 1. Asia Pacific Radiation Oncology Market Segmentation, by Country
Figure 2. Radiation Oncology Market - Key Market Dynamics
Figure 3. Statistics at Glance, Global, 2022
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Radiation Oncology Market Revenue (US$ Million), 2021-2031
Figure 6. Radiation Oncology Market Share (%) - by Types (2023 and 2031)
Figure 7. External Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Internal Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 9. Radiation Oncology Market Share (%) - by Application (2023 and 2031)
Figure 10. Breast Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. Prostate Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 12. Lung Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Head and Neck Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. Cervical Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 15. Others: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Asia Pacific Radiation Oncology Market, by Key Countries - Revenue (2023) (US$ Million)
Figure 17. Asia Pacific: Radiation Oncology Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 18. China: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 19. Japan: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 20. India: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 21. Australia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 22. South Korea: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 23. Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 24. Growth Strategies in Radiation Oncology Market